Roxadustat treatment for erythropoiesis-stimulating agent-hyporesponsive anemia in maintenance hemodialysis patients

Song, J; Chen, XJ; Zhou, LS; Yu, WH; Liu, H; Yuan, F

Yuan, F (通讯作者)，Cent South Univ, Xiangya Hosp 2, Dept Nephrol, Renmin Rd 139, Changsha 410011, Peoples R China.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2023; 51 (10):

Abstract

Objective: Hyporesponsiveness to erythropoiesis-stimulating agents (ESAs) is a prevalent problem affecting hemodialysis (HD) patients. Roxadustat is a......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索